![Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica](https://cdn.awsli.com.br/300x300/476/476175/produto/33796109/adb4eb413d.jpg)
Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica
![Schematic structures of pegfilgrastim. Notes: (A) A recombinant form of... | Download Scientific Diagram Schematic structures of pegfilgrastim. Notes: (A) A recombinant form of... | Download Scientific Diagram](https://www.researchgate.net/profile/Roberto-Guariglia/publication/291823565/figure/fig1/AS:613883194654722@1523372567340/Schematic-structures-of-pegfilgrastim-Notes-A-A-recombinant-form-of-G-CSF-to-which-a.png)
Schematic structures of pegfilgrastim. Notes: (A) A recombinant form of... | Download Scientific Diagram
![Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times](https://img.etimg.com/photo/msid-60010881,quality-100/.jpg)
Intas Pharmaceuticals: Intas eyes Teva's oncology, women's health divisions in Europe - The Economic Times
![Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780444640819000061-f06-01-9780444640819.jpg)
Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect
![Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland](https://www.archivesofmedicalscience.com/f/pictures/140623_bf70d.jpg)
Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland
![Frontiers | Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting | Oncology Frontiers | Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/655355/655355_Thumb_400.jpg)
Frontiers | Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting | Oncology
![Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile - Abdolzade‐Bavil - 2016 - The Journal of Clinical Pharmacology - Wiley Online Library Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile - Abdolzade‐Bavil - 2016 - The Journal of Clinical Pharmacology - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/cd8a4c53-d3fb-452f-8bc2-d8f511f0a210/jcph578-fig-0002-m.jpg)
Differential sensitivity of lipegfilgrastim and pegfilgrastim to neutrophil elastase correlates with differences in clinical pharmacokinetic profile - Abdolzade‐Bavil - 2016 - The Journal of Clinical Pharmacology - Wiley Online Library
![Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals](http://images.chemnet.com/service/drug_dict/098/11098_1.jpg)
Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals
![LONG-ACTING G-CSF (LIPEGFILGRASTIM, “LONQUEX”) FOR STEM CELL.... EHA Library. Danylesko I. Jun 15 2019; 267164 LONG-ACTING G-CSF (LIPEGFILGRASTIM, “LONQUEX”) FOR STEM CELL.... EHA Library. Danylesko I. Jun 15 2019; 267164](https://library.ehaweb.org/image/abstract/eha_2019/EHA-1516/ImagePictures_6885492.png)
LONG-ACTING G-CSF (LIPEGFILGRASTIM, “LONQUEX”) FOR STEM CELL.... EHA Library. Danylesko I. Jun 15 2019; 267164
![Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780444640819000061-f06-02-9780444640819.jpg)
Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study - ScienceDirect
![Fillable Online newworldhealthcare Teva Lonquex Referral Form for Amend Proof V2 - newworldhealthcare Fax Email Print - pdfFiller Fillable Online newworldhealthcare Teva Lonquex Referral Form for Amend Proof V2 - newworldhealthcare Fax Email Print - pdfFiller](https://www.pdffiller.com/preview/371/412/371412563.png)